Renaissance BioScience Corp. Secures Additional Patents for Acrylamide-Reducing Yeast Technology

    VANCOUVER, BC, November 07, 2023 /24-7PressRelease/ -- Renaissance BioScience Corp., a leader in bioengineering for the global food industry, is pleased to announce that it has recently been granted patents for its non-GMO acrylamide-reducing yeast from regulatory authorities in Denmark, France, Great Britain, Italy, Sweden, Mexico, Ukraine, and South Africa. These patents join its portfolio of patents in ten other key markets, further strengthening the company's intellectual property position.

Renaissance's CSO and Office of the CEO, Dr. John Husnik commented on the newly granted patents: "Acrylamide is a global public health concern, particularly for our children, who consume more than adults due to their daily diet of many common foods that unfortunately contain this carcinogen and neurotoxin. We are pleased that our acrylamide-reducing yeast is finding acceptance and being commercialized by food manufacturers in markets all around the world to reduce the presence of this contaminant in their products. Receiving these additional patent grants is important to protect the use of our acrylamide-reducing yeast in many different and important food manufacturing applications."

The Fight Against Acrylamide
Acylamide, a probable carcinogen and genotoxin and confirmed neurotoxin, forms naturally when carbohydrate-rich foods like rice, grains and potatoes are cooked at temperatures above 120°C (248°F). Prolonged acrylamide consumption is linked to increased risk of neurological disorders, metabolic syndrome, cardiovascular disease and obesity.

In addition, recent studies are showing links between acrylamide consumption and human neurological and neurodivergent mental health issues, including anxiety and depression. Acrylamide was first discovered to be widespread in many different foods worldwide in the early 2000s and since then, has prompted a number of regulatory bodies worldwide to increasingly regulate its presence in foods and beverages as a significant public health issue.

These increasing acrylamide regulations are leading manufacturers to search for a clean-label solution to reduce acrylamide in their products while maintaining the same quality and costs.

The Solution: Acrylamide-Reducing-Yeast
Renaissance created a non-GMO, organic suitable yeast, sold globally as Acryleast™ and Acryleast Pro™, and as Acrylow™ in Scandinavia, which is used in standard manufacturing processes to naturally reduce acrylamide levels by up to 90%. The products supplied by Renaissance's partners, Kerry Group, a global leader in sustainable nutrition, and Orkla Food Ingredients, a leading supplier of branded consumer goods, allow food manufacturers to drastically reduce the acrylamide content of their products with minimal to no disruption on their operations.

About Renaissance BioScience Corp.
Headquartered in Vancouver, Canada, Renaissance is a leading bioengineering company whose platform technologies are used to develop innovative, market-ready, functional microorganisms to address a broad range of environmental, health and industrial challenges. Renaissance technologies create products for multiple end-use industries, including food & beverage, agriculture, animal and human health and energy. Detailed information about the Renaissance group of companies is available at www.renaissancebioscience.com.

# # #